GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PolyPeptide Group AG (XSWX:PPGN) » Definitions » Gross-Profit-to-Asset %

PolyPeptide Group AG (XSWX:PPGN) Gross-Profit-to-Asset % : 5.18% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is PolyPeptide Group AG Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. PolyPeptide Group AG's annualized Gross Profit for the quarter that ended in Dec. 2023 was CHF31.7 Mil. PolyPeptide Group AG's average Total Assets over the quarter that ended in Dec. 2023 was CHF612.3 Mil. Therefore, PolyPeptide Group AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 5.18%.


PolyPeptide Group AG Gross-Profit-to-Asset % Historical Data

The historical data trend for PolyPeptide Group AG's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PolyPeptide Group AG Gross-Profit-to-Asset % Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 19.48 21.02 20.23 8.64 0.72

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.19 12.47 5.13 -4.16 5.18

Competitive Comparison of PolyPeptide Group AG's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, PolyPeptide Group AG's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PolyPeptide Group AG's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PolyPeptide Group AG's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where PolyPeptide Group AG's Gross-Profit-to-Asset % falls into.



PolyPeptide Group AG Gross-Profit-to-Asset % Calculation

PolyPeptide Group AG's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=4.378/( (568.219+649.862)/ 2 )
=4.378/609.0405
=0.72 %

PolyPeptide Group AG's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=31.714/( (574.698+649.862)/ 2 )
=31.714/612.28
=5.18 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


PolyPeptide Group AG Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of PolyPeptide Group AG's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


PolyPeptide Group AG (XSWX:PPGN) Business Description

Traded in Other Exchanges
Address
Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives a majority of its revenue from Europe and Asia.

PolyPeptide Group AG (XSWX:PPGN) Headlines

No Headlines